Primary Cells

Updated: 2026-09-12

Overview

Primary cells are harvested directly from human or animal tissues through enzymatic or mechanical dissociation. Unlike immortalized cell lines, they undergo a finite number of divisions before entering senescence, making them biologically closer to in vivo conditions. Their use has surged in translational research due to better predictability for clinical outcomes. Common sources include hepatocytes, keratinocytes, and cardiac myocytes. Procurement requires ethical approvals for human-derived cells, and quality benchmarks include viability (>80%), purity (flow cytometry), and absence of microbial contamination. Specialized media formulations are often needed to maintain cell-specific functions.

Key Features

Primary cells exhibit donor-specific genetic and phenotypic traits, enabling studies on inter-individual variability. They retain tissue-specific markers, metabolic pathways, and drug response profiles lost in immortalized lines. For example, primary hepatocytes express cytochrome P450 enzymes critical for pharmacokinetic studies. However, their limited proliferative capacity necessitates careful planning for experimental timelines. Batch-to-batch variability can occur due to donor age, health status, or isolation protocols. Cryopreservation techniques like slow freezing in DMSO-containing media help standardize supply for reproducible experiments.

Application Areas

In drug discovery, primary cells screen compound toxicity and efficacy with higher clinical relevance than artificial models. Cancer research utilizes patient-derived tumor cells for personalized therapy testing. Regenerative medicine employs mesenchymal stem cells for differentiation studies. They’re also vital in virology (e.g., primary bronchial epithelial cells for respiratory virus research) and immunology (PBMCs for vaccine development). Emerging applications include 3D organoid cultures and microphysiological systems that mimic human organ functions.

Precautions

Handling requires biosafety cabinets to prevent contamination. Cells must be cultured in validated media with growth factors (e.g., EGF for epithelial cells) and substrate coatings (collagen for adherence). Mycoplasma testing is mandatory, and antibiotics should be minimized to avoid masking infections. Short-term experiments are preferred; prolonged cultures risk phenotypic drift. Ethical sourcing is critical—human cells need informed consent, and animal-derived cells require IACUC protocols. Shipping conditions (liquid nitrogen vapor phase) and thawing procedures significantly impact viability.

B2B Procurement Guide

Reputable suppliers provide certificates of analysis including viability, doubling time, and marker expression (e.g., CD31 for endothelial cells). Bulk purchases may offer discounts, but confirm storage stability—some primary cells lose functionality beyond 3 passages. Consider co-culture systems if studying cell interactions (e.g., kupffer cells with hepatocytes). For niche applications, customized isolation services are available. Logistics should prioritize cryoshippers with temperature tracking to ensure cell integrity upon arrival.